Zura Bio initiates Phase II systemic sclerosis treatment trial
The global placebo-controlled trial involves nearly 80 subjects with early diffuse cutaneous systemic sclerosis.
Clinical Trials
GSK’s combo therapy trial for advanced ovarian cancer meets primary endpoint
Alumis reports positive outcomes from Phase I trial of TYK2 inhibitor
MSD’s DOR/ISL regimen meets primary efficacy hypotheses in HIV-1 treatment trials
Sarepta completes subject dosing in Phase III LGMD2E/R4 therapy trial
Remedy Plan commences dosing in Phase I cancer therapy trial
Precision gains CTA approval in Hong Kong for chronic hepatitis B therapy trial
Immunocore doses first subject in gastrointestinal cancer therapy trial
